127 related articles for article (PubMed ID: 25252508)
1. Utilization of systemic palliative chemotherapy at the end of life: a local experience.
Abdul Monem E; Mehdi I; Al Bahrani BJ; Nada AM; Al Kharusi S
J Pak Med Assoc; 2014 Aug; 64(8):863-8. PubMed ID: 25252508
[TBL] [Abstract][Full Text] [Related]
2. The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.
Tse DM; Chan KS; Lam WM; Leu K; Lam PT
Palliat Med; 2007 Jul; 21(5):425-33. PubMed ID: 17901102
[TBL] [Abstract][Full Text] [Related]
3. The utilization of palliative care in gynecologic oncology patients near the end of life.
Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
[TBL] [Abstract][Full Text] [Related]
4. Aggressiveness of cancer-care near the end-of-life in Korea.
Keam B; Oh DY; Lee SH; Kim DW; Kim MR; Im SA; Kim TY; Bang YJ; Heo DS
Jpn J Clin Oncol; 2008 May; 38(5):381-6. PubMed ID: 18411260
[TBL] [Abstract][Full Text] [Related]
5. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
6. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis.
Braga S; Miranda A; Fonseca R; Passos-Coelho JL; Fernandes A; Costa JD; Moreira A
Psychooncology; 2007 Sep; 16(9):863-8. PubMed ID: 17245696
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.
Wein L; Rowe C; Brady B; Handolias D; Lipton L; Pook D; Stanley R; Haines I
Intern Med J; 2017 Mar; 47(3):280-283. PubMed ID: 27658500
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy use and associated factors among cancer patients near the end of life.
Yun YH; Kwak M; Park SM; Kim S; Choi JS; Lim HY; Lee CG; Choi YS; Hong YS; Kim SY; Heo DS
Oncology; 2007; 72(3-4):164-71. PubMed ID: 18097167
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cancer patients in their last month of life: aimless chemotherapy.
Assi T; El Rassy E; Tabchi S; Ibrahim T; Moussa T; Chebib R; El Karak F; Farhat F; Chahine G; Nasr F; Ghosn M; Kattan J
Support Care Cancer; 2016 Apr; 24(4):1603-8. PubMed ID: 26391890
[TBL] [Abstract][Full Text] [Related]
10. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
[TBL] [Abstract][Full Text] [Related]
11. Preliminary report of the integration of a palliative care team into an intensive care unit.
O'Mahony S; McHenry J; Blank AE; Snow D; Eti Karakas S; Santoro G; Selwyn P; Kvetan V
Palliat Med; 2010 Mar; 24(2):154-65. PubMed ID: 19825893
[TBL] [Abstract][Full Text] [Related]
12. Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?
Dalrymple JL; Levenback C; Wolf JK; Bodurka DC; Garcia M; Gershenson DM
Gynecol Oncol; 2002 May; 85(2):356-61. PubMed ID: 11972400
[TBL] [Abstract][Full Text] [Related]
13. Avoiding harmful palliative chemotherapy treatment in the end of life: development of a brief patient-completed questionnaire for routine assessment of performance status.
Näppä U; Lindqvist O; Axelsson B
J Support Oncol; 2012; 10(6):230-7. PubMed ID: 22951048
[TBL] [Abstract][Full Text] [Related]
14. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy.
Zdenkowski N; Cavenagh J; Ku YC; Bisquera A; Bonaventura A
Intern Med J; 2013 Nov; 43(11):1191-8. PubMed ID: 23870085
[TBL] [Abstract][Full Text] [Related]
15. Advance care planning and dying in nursing homes in Flanders, Belgium: a nationwide survey.
De Gendt C; Bilsen J; Stichele RV; Deliens L
J Pain Symptom Manage; 2013 Feb; 45(2):223-34. PubMed ID: 22917717
[TBL] [Abstract][Full Text] [Related]
16. Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care.
Magarotto R; Lunardi G; Coati F; Cassandrini P; Picece V; Ferrighi S; Oliosi L; Venturini M
Tumori; 2011; 97(5):573-7. PubMed ID: 22158486
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy at the end of life: Uncommon clinical practice?].
Santos Pérez MI; Godoy Díez M; Abajo Del Álamo C
J Healthc Qual Res; 2019; 34(4):201-207. PubMed ID: 31713531
[TBL] [Abstract][Full Text] [Related]
18. Treatment decisions and discontinuation of palliative chemotherapy near the end-of-life, in relation to socioeconomic variables.
Randén M; Helde-Frankling M; Runesdotter S; Strang P
Acta Oncol; 2013 Aug; 52(6):1062-6. PubMed ID: 23438360
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy use at the end of life. A retrospective single centre experience analysis.
Andreis F; Rizzi A; Rota L; Meriggi F; Mazzocchi M; Zaniboni A
Tumori; 2011; 97(1):30-4. PubMed ID: 21528660
[TBL] [Abstract][Full Text] [Related]
20. Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.
Gonsalves WI; Tashi T; Krishnamurthy J; Davies T; Ortman S; Thota R; Aldoss I; Ganta A; Kalaiah M; Didwaniya N; Eberle C; Ganti AK; Silberstein PT; Subbiah S
J Palliat Med; 2011 Nov; 14(11):1231-5. PubMed ID: 21877925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
